NCT00571610

Montreal Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device

A Single-Center, Open-Label, Single-Arm Pilot Study of the Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Implantable Device Used to Reduce Mitral Valve Regurgitation.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 5 (actual)
• Sponsor: Viacor · Industry
• Sex: All
• Age: 40 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Reduction in mitral regurgitation due to safe placement of a PTMA device in the coronary sinus.

Conditions

• Heart Failure
• Mitral Regurgitation

Interventions

Type	Name	Description
DEVICE	PTMA (Percutaneous Transvenous Mitral Annuloplasty) Implant	Percutaneous access from right or left subclavian vein, diagnostic assessment, then placement of the PTMA implant in the coronary sinus, great cardiac vein.

Timeline

• Start date: 2006-04-01
• Primary completion: 2008-04-01
• Completion: 2008-11-01
• First posted: 2007-12-12
• Last updated: 2008-11-06

Locations

1 site across 1 country: Canada